Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Anaphylaxis Treatment Market for 2024-2033?
The market for anaphylaxis treatment has seen exponential growth in the most recent years. This growth trajectory is set to propel the market from $5.73 billion in 2023 to $6.15 billion in 2024, with a compound annual growth rate (CAGR) of 7.3%. The upward direction in the historical period is credited to a surge in allergic reactions, more extensive acknowledgement of anaphylaxis, higher accessibility of epinephrine auto-injectors, as well as heightened public awareness and education along with healthcare professional training.
In the coming years, it’s anticipated that the anaphylaxis treatment market will experience substantial growth. The market is predicted to expand to $7.97 billion by 2028, with a compound annual growth rate (CAGR) of 6.7%. This significant growth throughout the forecast period is primarily due to advancements in biologic therapies, personalized treatment methods, international attentiveness to food safety, the rise in patient advocacy and empowerment, as well as improved emergency medical services. Key trends throughout the forecast period consist of the development of auto-injectors, the use of telemedicine for managing anaphylaxis, enhanced allergen immunotherapy, the introduction of biometric wearables for allergen detection, and increased collaborations in the field of allergy research.
Claim Your Free Sample of the Global Anaphylaxis Treatment Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp
What Drivers Are Enhancing the anaphylaxis treatment Market’s Growth?
An increase in food allergy occurrences is predicted to drive growth to the anaphylaxis treatment market. A food allergy is essentially an immune response to proteins found in foods. Treatments for anaphylaxis are meant to halt the development of severe allergic symptoms which can comprise skin reactions, mucosal surface reactions, respiratory difficulties, hypotension, and end-organ damage. To illustrate, Centers for Disease Control and Prevention, a governmental agency in the US, stated in January 2023, that in 2021, 31.8% of adults over 18 indicated they suffered from eczema, seasonal allergies, or a food allergy. A quarter of adults (25.7%) had seasonal allergies, 6.2% suffered from food allergies, and 7.3% were affected by eczema. Consequently, this increase in food allergy occurrences is stimulating the anaphylaxis treatment market’s growth.
What Segments Are Central to the Anaphylaxis Treatment Market?
1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
What Emerging Trends Are Influencing Anaphylaxis Treatment Industry Dynamics?
The emergence of product evolution is an emerging trend in the anaphylaxis treatment market. Leading companies in the anaphylaxis treatment sphere are innovating their products to maintain their market standing. For instance, Aquestive Therapeutics Inc., a pharmaceutical enterprise based in the US, secured Fast Track status for AQST-109 from the Food and Drug Administration in April 2022. This status has been granted for treatment of extreme allergic reactions including anaphylaxis. Aquestive is now progressing with the clinical trials of AQST-109, a novel and unique orally administered epinephrine product candidate. It has shown similar clinical results to autoinjectors (like EpiPen and Auvi-Q) for dealing with allergy-related emergencies, such as anaphylaxis.
Order Now for Fast Delivery of Your Anaphylaxis Treatment Market Report!
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
Which Geographic Locations Are Critical to the Growth of the Anaphylaxis Treatment Market?
North America was the largest region in the anaphylaxis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Anaphylaxis Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the anaphylaxis treatment market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Anaphylaxis Treatment Market Include
1. Anaphylaxis Treatment Market Executive Summary
2. Anaphylaxis Treatment Market Segments
3. Anaphylaxis Treatment Market Size And Template Market Growth Rate
4. Key Anaphylaxis Treatment Market Trends
5. Major Anaphylaxis Treatment Market Drivers
……
25. Key Mergers And Acquisitions In The Anaphylaxis Treatment Market
26. Top Anaphylaxis Treatment Companies
27. Anaphylaxis Treatment Market Opportunities And Strategies
28. Anaphylaxis Treatment Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
